GILD

Gilead Sciences (GILD)

Gilead Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GILD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/14	08:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/14	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/13	05:45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/13	05:43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	21:30	Business Wire	Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/12	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/09/10	21:00	Business Wire	Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies	NASDAQ:GILD	Gilead Sciences Inc
2024/09/05	21:00	Business Wire	Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung Cancer	NASDAQ:GILD	Gilead Sciences Inc
2024/08/30	04:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/08/29	05:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/08/22	05:05	Business Wire	Gilead Sciences to Present at Upcoming Investor Conferences	NASDAQ:GILD	Gilead Sciences Inc
2024/08/15	03:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/08/15	02:59	Business Wire	Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA	NASDAQ:GILD	Gilead Sciences Inc
2024/08/14	05:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/08/13	05:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/08/09	06:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GILD	Gilead Sciences Inc
2024/08/09	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GILD	Gilead Sciences Inc
2024/08/09	05:02	Business Wire	Gilead Sciences Announces Second Quarter 2024 Financial Results	NASDAQ:GILD	Gilead Sciences Inc
2024/08/08	18:55	IH Market News	U.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices Stall	NASDAQ:GILD	Gilead Sciences Inc
2024/07/27	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/07/26	05:05	Business Wire	Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024	NASDAQ:GILD	Gilead Sciences Inc
2024/07/25	22:15	Business Wire	Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline	NASDAQ:GILD	Gilead Sciences Inc
2024/07/24	17:30	Business Wire	Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024	NASDAQ:GILD	Gilead Sciences Inc
2024/07/22	17:00	Business Wire	Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia	NASDAQ:GILD	Gilead Sciences Inc
2024/07/17	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GILD	Gilead Sciences Inc